1-5 of 5
Brian G. Durie
Close
Sort by
Journal Articles

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders - a Study of the International Myeloma Working Group

Jens Hillengass, MD, Lia A. Moulopoulos, MD, Stefan Delorme, MD, Vassilis Koutoulidis, MD, Thomas Hielscher, Jessica Engelhart, Matthew T. Drake, MD PhD, S. Vincent Rajkumar, MD, Brian Oestergaard, MD, Niels Abildgaard, MD Professor, Maja Hinge, MD, Torben Plesner, Professor, Yasuhito Suehara, MD, Kosei Matsue, MD PhD, Jo Caers, Nadia Withofs, MD, Meletios A Dimopoulos, Hartmut Goldschmidt, MD, Suzanne Lentzsch, MD PhD, Brian G Durie, MD, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4468.
https://doi.org/10.1182/blood.V128.22.4468.4468
Published: 2016
Journal Articles

Large Scale Evaluation of Genetic Variation and the Risk of Multiple Myeloma.

Sonja I Berndt, David C Johnson, John Crowley, Brian G Durie, MD, Robert Hoover, Michael Katz, Nathaniel Rothman, Brian G. Van Ness, PhD, Dalsu Baris, MD, PhD, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1679.
https://doi.org/10.1182/blood.V112.11.1679.1679
Published: 2008
Journal Articles

An Integrated Pharmacogenomic Strategy for the Definition of Thalidomide Response Signatures in Presenting Cases of Multiple Myeloma.

Gareth J. Morgan, MD, PhD, Matthew W. Jenner, MD, Brian A. Walker, PhD, David C. Johnson, BSc, Paola A. Leone, PhD, Fiona M. Ross, PhD, Mark T. Drayson, MD, PhD, Brian G. Van Ness, Brian G. Durie, Nicholas J. Dickens, PhD, J. Anthony Child, R.G. Owen, Faith E. Davies, MD
Journal: Blood
Blood (2007) 110 (11): 2493.
https://doi.org/10.1182/blood.V110.11.2493.2493
Published: 2007
Journal Articles

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

Brian G. Van Ness, PhD, John C. Crowley, Ph.D., Christine Ramos, B.S., Suzanne M. Grindle, Ph.D., Antje Hoering, Ph.D., Jeff Haessler, M.S., Susanna Jacobus, M.S., Brian G. Durie, MD, Michael Katz, Ph.D., Vincent S. Rajkumar, MD, Bart Barlogie, MD, David C. Johnson, Ph.D., Gareth J. Morgan, MD
Journal: Blood
Blood (2006) 108 (11): 131.
https://doi.org/10.1182/blood.V108.11.131.131
Published: 2006
Journal Articles

SWOG 0204; Phase 2 Trial of Thalidomide (T) + Dexamethasone (D) Induction Followed by Tandem Autotransplant (TAT) and Prednisone (P) + T Maintenance for Multiple Myeloma (MM).

Mohamad A. Hussein, MD, Jason McCoy, MS, Andrzej Jakubowiak, MD, PhD, Brian G. Durie, MD, John J. Crowley, MD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1169.
https://doi.org/10.1182/blood.V106.11.1169.1169
Published: 2005